Effect of N-acetyl-cysteine (NAC) added to fenoldopam or dopamine on end-tidal carbon dioxide and mean arterial pressure at time of renal artery declamping during cadaveric kidney transplantation.

@article{Sorbello2010EffectON,
  title={Effect of N-acetyl-cysteine (NAC) added to fenoldopam or dopamine on end-tidal carbon dioxide and mean arterial pressure at time of renal artery declamping during cadaveric kidney transplantation.},
  author={M. Sorbello and G. Morello and L. Parrinello and C. Molino and D. Rinzivillo and R. Pappalardo and M. Cutuli and D. Corona and P. Veroux and M. Veroux},
  journal={Transplantation proceedings},
  year={2010},
  volume={42 4},
  pages={
          1056-60
        }
}
N-acetyl-cysteine (NAC) is known to be a powerful antioxidant used to prevent renal damage. Our deceased-donor kidney transplantation protocol administered an NAC bolus at the time of declamping of the renal artery to reduce the potential oxidative damage with ischemia-reperfusion. The aim of injury this study was to compare the effects of NAC added to a continuous infusion of either fenoldopam or dopamine during kidney recipient anesthesia on mean arterial pressure (MAP) and end-tidal carbon… Expand
Possible mechanisms for N-acetyl cysteine and taurine in ameliorating acute renal failure induced by cisplatin in rats
TLDR
It is suggested that oxidative stress and inflammation are involved in the pathogenesis of CP-induced acute renal failure and the inhibition of the inflammatory biomarkers by NAC or TAU after CP administration may play a central role in modulation of nephrotoxicity induced by CP. Expand
Protective Effects of L-Carnitine Against Delayed Graft Function in Kidney Transplant Recipients: A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.
TLDR
This study showed no protective effects of oral L- carnitine supplementation against DGF occurrence recipients; however, 3-month graft loss was lower in the L-c Carnitine supplemented group. Expand
Heme-Oxygenase and Kidney Transplantation: A Potential for Target Therapy?
TLDR
Heme-oxygenase induction has been proved to provide a significant reduction of inflammatory response and a reduction of ischemia and reperfusion injury in organ transplantation, as well as providing a Reduction of incidence of acute rejection. Expand
The Effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trials.
TLDR
A systematic review of randomized trials published in the last 20 yr found that inotrope/vasopressor therapy is not associated with differences in mortality in the overall population and in the majority of subsettings. Expand
Predictive Value of Intraoperative Doppler Flowmetry for Delayed Graft Function in Kidney Transplantation: A Pilot Study.
TLDR
Intraoperative arterial graft flowmetry seems to be an effective tool to identify grafts at high risk of delayed graft function (DGF) in kidney transplantation. Expand
Systematic review on the treatment of deceased organ donors.
TLDR
There is currently insufficient evidence to conclude that any particular drug treatment or any intervention in the deceased donor improves long-term graft or patient survival after transplantation. Expand

References

SHOWING 1-10 OF 15 REFERENCES
Beneficial effect of N-acetyl-cysteine on renal injury triggered by ischemia and reperfusion.
TLDR
The protective effect of N-acetyl-cysteine was better observed at high concentrations and early times. Expand
Fenoldopam vs dopamine as a nephroprotective strategy during living donor kidney transplantation: preliminary data.
TLDR
Fenoldopam compared with dopamine resulted in better nephroprotective effects, and no adverse events were recorded, and side effects were minimal. Expand
Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury.
TLDR
In chronic renal failure patients, the improvement in renal function induced by post-radiocontrast administration of N-acetylcysteine is strongly associated with suppression of oxidant stress-mediated proximal tubular injury. Expand
Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy.
TLDR
It is suggested that fenoldopam mesylate is a promising prophylactic agent for RCN and that larger multicenter trials should be conducted to prove its efficacy. Expand
N-Acetylcysteine for patients with prolonged hypotension as prophylaxis for acute renal failure (NEPHRON)*
TLDR
Trends toward reduced incidence of acute renal failure in patients with baseline SOFA score >8, reduced SOFA scores during the first 4 days, and reduced mortality in patients <65 yrs of age are provocative but require further study to determine their clinical significance. Expand
A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients*
TLDR
In critically ill patients, a continuous infusion of fenoldopam at 0.1 &mgr;g/kg/min does not cause any clinically significant hemodynamic impairment and improves renal function compared with renal dose dopamine, and in the setting of acute early renal dysfunction, the attempt to reverse renal hypoperfusion with fen oldopam is more effective than with low-dose dopamine. Expand
Reduction of glomerular hyperfiltration by dopamine D(2)-like receptor blockade in experimental diabetes mellitus.
  • G. Luippold, M. Beilharz, B. Mühlbauer
  • Medicine
  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2001
TLDR
The data suggest that dopaminergic mechanisms are involved in the changes in renal haemodynamics during early experimental diabetes mellitus in rats. Expand
The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects.
TLDR
A dose of fenoldopam that increases renal blood flow without inducing hypotension in normotensive patients is sought and the role of volume status (sodium replete vs. deplete) in these effects is explored to explore. Expand
Use of dopamine in acute renal failure: A meta-analysis
TLDR
The use of low-dose dopamine for the treatment or prevention of acute renal failure cannot be justified on the basis of available evidence and should be eliminated from routine clinical use. Expand
Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients.
TLDR
The hypothesis that fenoldopam may reduce the risk of acute renal failure in patients in whom endogenous and exogenous cathecolamines action may induce a renal vascular constrictive condition is supported. Expand
...
1
2
...